Vitamin D and cardiovascular disease and cancer: Not too much and not too little? The need for clinical trials

Women's Health

Volumn 7, Issue 4, 2011, Pages 419-424

  Melamed, Michal L ^a   Manson, JoAnn E ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

25 hydroxyvitamin D; cancer; cardiovascular disease; diabetes mellitus; hypertension; pancreatic cancer; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; PLACEBO; VITAMIN D;

BLOOD VESSEL CALCIFICATION; BREAST CANCER; CANCER MORTALITY; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL STUDY; COLORECTAL CANCER; DISEASE ACTIVITY; DISEASE ASSOCIATION; EVIDENCE BASED MEDICINE; HUMAN; NEOPLASM; NONHUMAN; OBESITY; OUTCOME ASSESSMENT; PANCREAS CANCER; PATHOGENESIS; PREVALENCE; REVIEW; RISK FACTOR; SEX DIFFERENCE; VITAMIN SUPPLEMENTATION;

CALCINOSIS; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH STATUS; HUMANS; MALE; NEOPLASMS; PANCREATIC NEOPLASMS; VASCULAR DISEASES; VITAMIN D;

EID: 79960952080     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.11.18     Document Type: Review

References (59)

1. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J. Clin. Invest. 110, 229-238 (2002). (Pubitemid 34787360)
2. Xiang W, Kong J, Chen S et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am. J. Physiol. Endocrinol. Metab. 288, E125-E132 (2005). (Pubitemid 40023798)
3. Kasuga H, Hosogane N, Matsuoka K et al. Characterization of transgenic rats constitutively expressing vitamin D-24- hydroxylase gene. Biochem. Biophys. Res. Commun. 297, 1332-1338 (2002). (Pubitemid 35216393)
4. Kunitomo M, Kinoshita K, Bando Y. Experimental atherosclerosis in rats fed a vitamin D, cholesterol-rich diet. J. Pharmacobiodyn. 4, 718-723 (1981). (Pubitemid 12234248)
5. Wu SH, Ho SC, Zhong L. Effects of vitamin D supplementation on blood pressure. South Med. J. 103, 729-737 (2010).
6. Pittas AG, Chung M, Trikalinos T et al. Systematic review: vitamin D and cardiometabolic outcomes. Ann. Intern. Med. 152, 307-314 (2010).
7. Parker J, Hashmi O, Dutton D et al. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 65, 225-236 (2010).
8. Zittermann A, Frisch S, Berthold HK et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am. J. Clin. Nutr. 89, 1321-1327 (2009).
9. Semba RD, Houston DK, Bandinelli S et al. Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur. J. Clin. Nutr. 64, 203-209 (2010).
10. Dobnig H, Pilz S, Scharnagl H et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch. Intern. Med. 168, 1340-1349 (2008). (Pubitemid 351930842)
11. Pilz S, Dobnig H, Nijpels G et al. Vitamin D and mortality in older men and women. Clin. Endocrinol. (Oxford) 71, 666-672 (2009).
12. Mehta S, Giovannucci E, Mugusi FM et al. Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PLoS ONE 5, e8770 (2010).
13. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch. Intern. Med. 168, 1629-1637 (2008).
14. Wang TJ, Pencina MJ, Booth SL et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 117, 503-511 (2008).
15. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch. Intern. Med. 168, 1174-1180 (2008). (Pubitemid 351831400)
16. Zittermann A, Schleithoff SS, Koerfer R. Putting cardiovascular disease and vitamin D insufficiency into perspective. Br. J. Nutr. 94, 483-492 (2005). (Pubitemid 41555486)
17. Pilz S, Dobnig H, Fischer JE et al. Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 39, 2611-2613 (2008).
18. Poole KE, Loveridge N, Barker PJ et al. Reduced vitamin D in acute stroke. Stroke 37, 243-245 (2006). (Pubitemid 43732081)
19. Pilz S, Marz W, Wellnitz B et al. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. J. Clin. Endocrinol. Metab. 93, 3927-3935, (2008).
20. Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Korfer R, Stehle P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J. Am. Coll. Cardiol. 41, 105-112 (2003). (Pubitemid 36044411)
21. Melamed ML, Muntner P, Michos ED et al. Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler. Thromb. Vasc. Biol. 28, 1179-1185 (2008).
22. Anderson JL, May HT, Horne BD et al. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am. J. Cardiol. 106, 963-968 (2010).
23. Wang L, Manson JE, Song Y, Sesso HD. Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann. Intern. Med. 152, 315-323 (2010).
24. Rajasree S, Rajpal K, Kartha CC et al. Serum 25-hydroxyvitamin D3 levels are elevated in South Indian patients with ischemic heart disease. Eur. J. Epidemiol. 17, 567-571 (2001). (Pubitemid 34252685)
25. Freedman BI, Wagenknecht LE, Hairston KG et al. Vitamin D, adiposity, and calcified atherosclerotic plaque in African-Americans. J. Clin. Endocrinol. Metab. 95, 1076-1083 (2010).
26. Xie SP, James SY, Colston KW. Vitamin D derivatives inhibit the mitogenic effects of IGF-I on MCF-7 human breast cancer cells. J. Endocrinol. 154, 495-504 (1997). (Pubitemid 27375045)
27. Koga M, Eisman JA, Sutherland RL. Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells. Cancer Res. 48, 2734-2739 (1988).
28. James SY, Mackay AG, Colston KW. Effects of 1,25 dihydroxyvitamin D3 and its analogues on induction of apoptosis in breast cancer cells. J. Steroid Biochem. Mol. Biol. 58, 395-401 (1996). (Pubitemid 26348973)
29. Diaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res. 60, 2304-2312 (2000). (Pubitemid 30225198)
30. Jiang F, Bao J, Li P, Nicosia SV, Bai W. Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase. J. Biol. Chem. 279, 53213-53221 (2004). (Pubitemid 40051824)
31. Moreno J, Krishnan AV, Swami S, Nonn L, Peehl DM, Feldman D. Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells. Cancer Res. 65, 7917-7925 (2005). (Pubitemid 41297270)
32. Krishnan AV, Swami S, Peng L, Wang J, Moreno J, Feldman D. Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy. Endocrinology 151, 32-42 (2010).
33. Sundaram S, Chaudhry M, Reardon D, Gupta M, Gewirtz DA. The vitamin D3 analog EB 1089 enhances the antiproliferative and apoptotic effects of adriamycin in MCF-7 breast tumor cells. Breast Cancer Res. Treat. 63, 1-10 (2000).
34. Campbell MJ, Elstner E, Holden S, Uskokovic M, Koeffler HP. Inhibition of proliferation of prostate cancer cells by a 19-nor-hexafluoride vitamin D3 analogue involves the induction of p21waf1, p27kip1 and E-cadherin. J. Mol. Endocrinol. 19, 15-27 (1997). (Pubitemid 27345239)
35. Li P, Li C, Zhao X, Zhang X, Nicosia SV, Bai W. p27(Kip1) stabilization and G(1) arrest by 1,25-dihydroxyvitamin D(3) in ovarian cancer cells mediated through down-regulation of cyclin E/cyclin-dependent kinase 2 and Skp1-Cullin-F-box protein/Skp2 ubiquitin ligase. J. Biol. Chem. 279, 25260-25267 (2004). (Pubitemid 38756778)
36. Giovannucci E, Liu Y, Rimm EB et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J. Natl Cancer. Inst. 98, 451-459 (2006).
37. Freedman DM, Looker AC, Chang SC, Graubard BI. Prospective study of serum vitamin D and cancer mortality in the United States. J. Natl Cancer Inst. 99, 1594-1602 (2007).
38. Freedman DM, Looker AC, Abnet CC, Linet MS, Graubard BI. Serum vitamin D and cancer mortality in the NHANES III Study (1988-2006).Cancer Res. 70(21), 8587-8597 (2010).
39. Pilz S, Dobnig H, Winklhofer-Roob B et al. Low serum levels of 25-hydroxyvitamin D predict fatal cancer in patients referred to coronary angiography. Cancer Epidemiol. Biomarkers Prev. 17, 1228-1233 (2008).
40. Helzlsouer KJ: Overview of the cohort consortium vitamin D pooling project of rarer cancers. Am. J. Epidemiol. 172, 4-9 (2010).
41. Stolzenberg-Solomon RZ, Jacobs EJ, Arslan AA et al. Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: cohort consortium vitamin D pooling project of rarer cancers. Am. J. Epidemiol. 172, 81-93 (2010).
42. Lim HS, Roychoudhuri R, Peto J, Schwartz G, Baade P, Moller H. Cancer survival is dependent on season of diagnosis and sunlight exposure. Int. J. Cancer 119, 1530-1536 (2006). (Pubitemid 44258757)
43. Zhou W, Suk R, Liu G et al. Vitamin D is associated with improved survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol. Biomarkers Prev. 14, 2303-2309 (2005). (Pubitemid 41437829)
44. Porojnicu AC, Lagunova Z, Robsahm TE, Berg JP, Dahlback A, Moan J. Changes in risk of death from breast cancer with season and latitude: sun exposure and breast cancer survival in Norway. Breast Cancer Res. Treat. 102, 323-328 (2007). (Pubitemid 46474836)
45. Porojnicu A, Robsahm TE, Berg JP, Moan J. Season of diagnosis is a predictor of cancer survival. Sun-induced vitamin D may be involved: a possible role of sun-induced Vitamin D. J. Steroid Biochem. Mol. Biol. 103, 675-678 (2007). (Pubitemid 46420523)
46. Porojnicu AC, Robsahm TE, Dahlback A et al. Seasonal and geographical variations in lung cancer prognosis in Norway. Does vitamin D from the sun play a role? Lung Cancer 55, 263-270 (2007). (Pubitemid 46350699)
47. Jenab M, Bueno-de-Mesquita HB, Ferrari P et al. Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations: a nested case-control study. BMJ 340, b5500 (2010).
48. Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H: Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment. Pharmacol. Ther. 30, 113-125 (2009).
49. Engel P, Fagherazzi G, Boutten A et al. Serum 25(OH) vitamin D and risk of breast cancer: a nested case-control study from the French E3N cohort. Cancer Epidemiol. Biomarkers Prev. 19, 2341-2350 (2010).
50. Gandini S, Boniol M, Haukka J et al. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int. J. Cancer 128(6), 1414-1424 (2010).
51. Yin L, Grandi N, Raum E, Haug U, Arndt V, Brenner H. Meta-analysis: serum vitamin D and breast cancer risk. Eur. J. Cancer 46, 2196-2205 (2010).
52. Stolzenberg-Solomon RZ, Vieth R, Azad A et al. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res. 66, 10213-10219 (2006). (Pubitemid 44672077)
53. Stolzenberg-Solomon RZ, Hayes RB, Horst RL, Anderson KE, Hollis BW, Silverman DT. Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res. 69, 1439-1447 (2009).
54. Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 326, 469 (2003).
55. Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP: Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am. J. Clin. Nutr. 85, 1586-1591 (2007). (Pubitemid 46890428)
56. Wactawski-Wende J, Kotchen JM, Anderson GL et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N. Engl. J. Med. 354, 684-696 (2006). (Pubitemid 43247139)
57. Chlebowski RT, Johnson KC, Kooperberg C et al. Calcium plus vitamin D supplementation and the risk of breast cancer. J. Natl Cancer Inst. 100, 1581-1591 (2008).
58. LaCroix AZ, Kotchen J, Anderson G et al. Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial. J. Gerontol. A. Biol. Sci. Med. Sci. 64, 559-567 (2009).
59. Ross AC, Manson JE, Abrams SA et al. The 2011 Report on dietary reference intakes for calcium and vitamin D from the institute of medicine: what clinicians need to know. J. Clin. Endocrinol. Metab. 96(1), 53-58 (2010).